Alan T. Remaley, MD, PhD, discusses the development of a new peptide for reducing triglycerides to treat serious ailments like pancreatitis and heart disease.
This video is by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH). Dr. Alan T. Remaley is a senior investigator and the section chief of the Lipoprotein Metabolism Laboratory in the Cardiovascular and Pulmonary Branch at NHLBI.
Learn more: http://www.nhlbi.nih.gov
Follow us on Twitter: / nih_nhlbi
Like us on Facebook: / nhlbi
Follow us on LinkedIn: / national-heart-lung-and-blood-institute